Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Mirati Therapeutics Inc. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
coloncancercolorectalcancerkrasnsclcpancreaticcancer
advanced cancer, metastatic cancer, malignant neoplastic disease, kras, nsclc, colorectal cancer, colon cancer, pancreatic cancer, adagrasib, stk11 mutation, kras g12c, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 910648
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.